Search Login Register

Lovastatin (Mevacor) Summary

Description: A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.

Also Known As: Mevacor; 6-Methylcompactin; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); MK-803 Show All >>

Networked: 1199 relevant articles (122 outcomes, 262 trials/studies) for this Drug

Key Diseases for which Lovastatin is Relevant

  1. Hypercholesterolemia : 24 outcomes 46 studies in 221 results
  2. Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) : 10 outcomes 8 studies in 56 results
  3. Nephrotic Syndrome (Syndrome, Nephrotic) : 8 outcomes 4 studies in 19 results
  4. Neoplasms (Cancer) : 7 outcomes 17 studies in 140 results
  5. Hyperlipidemias (Hyperlipidemia) : 7 outcomes 11 studies in 59 results
Show All >>

Drugs Related to Lovastatin

  1. Cholesterol
  2. Simvastatin (Zocor)
  3. LDL Cholesterol
  4. Pravastatin (Pravachol)
  5. Lipoproteins (Lipoprotein)
  6. Colestipol (Colestid)
  7. Gemfibrozil (Lopid)
  8. Niacin (Nicotinic Acid)
  9. atorvastatin (Lipitor)
  10. fluvastatin
Show All >>

Therapies Related to Lovastatin

  1. Heart Transplantation (Grafting, Heart)
  2. Diet Therapy (Therapy, Diet)
  3. Combination Drug Therapy (Combination Chemotherapy)
  4. Continuous Ambulatory Peritoneal Dialysis (CAPD)
  5. Cardiopulmonary Resuscitation (CPR)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.